Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2015-07-08 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
关于公司股票复牌的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the resumption of trading (stock resumption) after a suspension due to a major matter. It mentions a previous suspension notice and states the stock will resume trading. There is no financial data, no detailed report, no voting results, no management changes, or other detailed disclosures. The content is a regulatory announcement about stock trading status related to a major event (management shareholding plan). This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2015-07-08 Chinese
关于管理层增持公司股份的公告
Director's Dealing Classification · 100% confidence The document is an announcement from the company's board regarding the management team's plan to increase their shareholdings in the company. It details the names, positions, and planned share purchase amounts of various management personnel. The document also explains the reasons for the share purchases, the source of funds, the method of purchase, and a commitment not to sell the shares within six months after the purchase. This is a report of personal share transactions by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document is not a full financial report, earnings release, or regulatory filing, but a specific announcement about insider share transactions.
2015-07-08 Chinese
独立董事关于收购昆明贝克诺顿制药有限公司49%股权的独立意见
Regulatory Filings Classification · 90% confidence The document is a statement of independent directors' opinions regarding the company's acquisition of 49% equity in another company. It discusses the legality and fairness of the acquisition process and its benefits to the company and shareholders. The document is short (400 characters) and does not contain financial statements or detailed financial data. It is an opinion related to a capital transaction but not a full capital/financing update report. It is not an announcement of voting results or a regulatory filing. Given the nature of the document as an independent directors' opinion on a specific transaction, it fits best under Regulatory Filings (RNS) as a miscellaneous regulatory announcement that does not fit other categories.
2015-07-08 Chinese
关于召开2015年第三次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2015 third extraordinary general meeting of shareholders (临时股东大会) of Kunming Pharmaceutical Group Co., Ltd. It includes details about the meeting date, voting methods, agenda items, and instructions for shareholders. It does not contain financial statements, audit results, or detailed management discussion. It is an announcement informing shareholders about the meeting and how to participate, rather than the actual meeting minutes or voting results. The document length is 2791 characters, which is relatively short and consistent with a meeting notice. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2015-07-08 Chinese
七届二十次监事会决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the supervisory board (监事会) of Kunming Pharmaceutical Group Co., Ltd. It details decisions made during a supervisory board meeting, including approval of an acquisition plan, resignation of a supervisor, and appointment of a new supervisor. The document is an official announcement of board/management changes and decisions, not a full report or financial statement. It does not contain financial data or detailed financial analysis, nor is it a regulatory filing or certification. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and focused on management decisions, consistent with MANG filings.
2015-07-07 Chinese
关于收购昆明贝克诺顿制药有限公司49%股权的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about the acquisition of 49% equity in Kunming Baker Norton Pharmaceutical Co., Ltd. by Kunming Pharmaceutical Group Co., Ltd. It includes transaction details, parties involved, financial data, contract terms, and impact on the company. The document is not a full annual or interim report, nor is it a simple announcement of a report. It is a capital transaction update involving acquisition of shares and related agreements. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2015-07-07 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.